Cytomegalovirus-associated hemophagocytic syndrome in a child with crohn disease receiving azathioprine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 39, Issue 4, 2004, Pages 418-421

  Babu, T G Lokesh ^a   Boctor, Dana ^a   Davey, Alyson ^a   Bond, Mason C ^a   Jacobson, Kevan ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; VIRUS ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD; CASE REPORT; CHILD; CROHN DISEASE; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; GENETICS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOLOGY; MALE; VIROLOGY;

ANTIBODIES, VIRAL; AZATHIOPRINE; CHILD; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; RNA, VIRAL;

EID: 27544456495     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200410000-00020     Document Type: Article

References (20)

1. Bouhnik Y, Lemann M, Scemama G, et al. Long-term follow-up of patients with Crohn’s disease treated with azathioprine or 6-mercatopurine. Lancet 1996;347:215-9.
2. Orchard TR, Jewell DP, Fraser AG. The efficacy of azathioprine for the treatment of inflammatory bowel disease. Gut 2002; 50;485-9.
3. Sofat N, Houghton J, Mchale J, Higgens CS. Azathioprine hypersensitivity. Ann Rheum Dis 2001;60:719-20.
4. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998;115:813-21.
5. Posthuma EFM, Westendorp RGJ, Van der sluys A, et al. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn’s disease with azathioprine. Gut 1995;36:311-3.
6. Komp DM, Mcnamara J, Bucklry P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989;73:2128-32.
7. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92-8.
8. Ohga S, Matsuzaki A, Nishizaki M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:291-8.
9. Ishii E, Ohga S, Aoki T, et al. Prognosis of children with viral associated hemophagocytic syndrome and malignant histiocytosis: correlation with interleukin-1 and tumor necrosis factor. Acta Haematol 1991;85:93-9.
10. Krensky AM, Clayberger C. Transplantation immunology. Clin Immunol 1994;41:819-39.
11. Kano Y, Shiohara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci 2000;22:196-204.
12. Henter J-I, Elinder G, Ost A, et al. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
13. Favara BE, Feller AC. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997;29:157-66.
14. Risdall RJ, Mckenna RW, Nesbit ME. Viral associated hemophagocytic syndrome. Cancer 1979;44:993-1002.
15. Sijpkens YWJ, Allart CF, Thomson J. Fever and progressive pancytopenia in a 20-year-old woman with Crohn’s disease. Ann Hematol 1996;72:286-290.
16. Lowry PW, Franklin CL, Weaver AL, et al. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine or balsalazide. Gut 2001;49: 656-64.
17. Castiglione F, Del Vecchio Blanco G, Rispo A, et al. Hepatitis related to cytomegalovirus infection in two patients with Crohn’s disease treated with azathioprine. Digest Liver Dis 2000;32:626-9.
18. Fisman DN. Hemophagocytic syndromes and Infection. Emerg Infect Dis 2000;6:601-8.
19. Sachiko K, Kazu O, Tokumitsu Y, et al. Hemophagocytic syndrome associated with fulminant ulcerative colitis and presumed acute pancreatitis. Am J Gastroenterol 1998;93:1956-59.
20. Stephan JL, Kone-paut C, Galambrun C, et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology 2001;40: 1285-92.